Daizo Oka

708 total citations
23 papers, 567 citations indexed

About

Daizo Oka is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daizo Oka has authored 23 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daizo Oka's work include Testicular diseases and treatments (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Bone health and treatments (3 papers). Daizo Oka is often cited by papers focused on Testicular diseases and treatments (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Bone health and treatments (3 papers). Daizo Oka collaborates with scholars based in Japan and United States. Daizo Oka's co-authors include Masashi Nakayama, Norio Nonomura, Kazuo Nishimura, Äkïhïko Okuyama, Yasutomo Nakai, Hitoshi Takayama, Masahiro Shiba, Yasuyuki Arai, Hitoshi Inoue and Akira Tsujimura and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Daizo Oka

23 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daizo Oka Japan 13 255 172 129 129 128 23 567
Yasuhide Kitagawa Japan 16 286 1.1× 292 1.7× 212 1.6× 116 0.9× 124 1.0× 45 789
Kazutaka Narimoto Japan 15 167 0.7× 259 1.5× 177 1.4× 85 0.7× 97 0.8× 39 622
Guanxiong Ding China 17 364 1.4× 213 1.2× 178 1.4× 189 1.5× 139 1.1× 40 691
Kuo-Pao Lai Taiwan 6 227 0.9× 240 1.4× 158 1.2× 95 0.7× 40 0.3× 6 499
Katsuyuki Kuratsukuri Japan 11 197 0.8× 285 1.7× 153 1.2× 81 0.6× 64 0.5× 42 587
Yota Yasumizu Japan 18 419 1.6× 367 2.1× 322 2.5× 180 1.4× 102 0.8× 78 927
Hsi Chin Wu Taiwan 11 216 0.8× 203 1.2× 130 1.0× 125 1.0× 59 0.5× 22 502
A A Sandberg United States 5 270 1.1× 235 1.4× 151 1.2× 84 0.7× 82 0.6× 7 584
Shaopeng Qiu China 18 468 1.8× 178 1.0× 194 1.5× 233 1.8× 155 1.2× 38 782
Jen‐Tai Lin Taiwan 8 304 1.2× 116 0.7× 89 0.7× 294 2.3× 124 1.0× 24 575

Countries citing papers authored by Daizo Oka

Since Specialization
Citations

This map shows the geographic impact of Daizo Oka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daizo Oka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daizo Oka more than expected).

Fields of papers citing papers by Daizo Oka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daizo Oka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daizo Oka. The network helps show where Daizo Oka may publish in the future.

Co-authorship network of co-authors of Daizo Oka

This figure shows the co-authorship network connecting the top 25 collaborators of Daizo Oka. A scholar is included among the top collaborators of Daizo Oka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daizo Oka. Daizo Oka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oka, Daizo, et al.. (2013). [Case of prostate cancer associated with bisphosphonate-related osteonecrosis of the jaw followed by retropharyngeal abscess].. PubMed. 59(9). 587–91. 3 indexed citations
2.
Hatano, Koji, Kazuo Nishimura, Yasutomo Nakai, et al.. (2012). Weekly low-dose docetaxel combined with estramustine and dexamethasone for Japanese patients with metastatic castration-resistant prostate cancer. International Journal of Clinical Oncology. 18(4). 704–710. 8 indexed citations
3.
Hayashi, Tetsuya, et al.. (2012). [A case of prostate cancer diagnosed by lymphadenectomy].. PubMed. 58(10). 557–60. 1 indexed citations
4.
Kawashima, Atsunari, Masashi Nakayama, Daizo Oka, et al.. (2011). Pulmonary metastasectomy in patients with renal cell carcinoma: a single-institution experience. International Journal of Clinical Oncology. 16(6). 660–665. 24 indexed citations
5.
Godoy, Alejandro, Elzbieta Kawinski, Yun Li, et al.. (2011). 614 5α-REDUCTASE TYPE 3 EXPRESSION IN HUMAN BENIGN AND MALIGNANT TISSUES: A COMPARATIVE ANALYSIS DURING PROSTATE CANCER PROGRESSION. The Journal of Urology. 185(4S). 2 indexed citations
6.
Godoy, Alejandro, Elzbieta Kawinski, Yun Li, et al.. (2010). 5α‐reductase type 3 expression in human benign and malignant tissues: A comparative analysis during prostate cancer progression. The Prostate. 71(10). 1033–1046. 84 indexed citations
7.
Kawashima, Atsunari, Masashi Nakayama, Yoichi Kakuta, et al.. (2010). Excision Repair Cross-Complementing Group 1 May Predict the Efficacy of Chemoradiation Therapy for Muscle-Invasive Bladder Cancer. Clinical Cancer Research. 17(8). 2561–2569. 53 indexed citations
8.
Nonomura, Norio, Akira Nagahara, Daizo Oka, et al.. (2009). Brain metastases from testicular germ cell tumors: A retrospective analysis. International Journal of Urology. 16(11). 887–893. 30 indexed citations
9.
Nagahara, Akira, Masashi Nakayama, Daizo Oka, et al.. (2009). SERPINE2 is a possible candidate promotor for lymph node metastasis in testicular cancer. Biochemical and Biophysical Research Communications. 391(4). 1641–1646. 24 indexed citations
10.
Arai, Yasuyuki, Norio Nonomura, Daizo Oka, et al.. (2008). The Growth-Inhibitory Effects of Dexamethasone on Renal Cell CarcinomaIn VivoandIn Vitro. Cancer Investigation. 26(1). 35–40. 23 indexed citations
11.
Takayama, Hitoshi, Norio Nonomura, Kazuo Nishimura, et al.. (2008). Decreased immunostaining for macrophage scavenger receptor is associated with poor prognosis of prostate cancer. British Journal of Urology. 103(4). 470–474. 15 indexed citations
12.
Inoue, Hitoshi, Yasuyuki Kojima, Masayuki Shiba, et al.. (2007). Somatic mutations of the von Hippel-Lindau disease gene in renal carcinomas occurring in patients with long-term dialysis. Nephrology Dialysis Transplantation. 22(7). 2052–2055. 14 indexed citations
13.
Oka, Daizo, Kazuo Nishimura, Masahiro Shiba, et al.. (2007). Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-κB. International Journal of Cancer. 120(12). 2576–2581. 82 indexed citations
14.
Nonomura, Norio, Daizo Oka, Kazuo Nishimura, et al.. (2007). Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors. International Journal of Urology. 14(6). 527–531. 14 indexed citations
15.
Nonomura, Norio, Hitoshi Takayama, Kazuo Nishimura, et al.. (2007). Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer. British Journal of Cancer. 97(7). 952–956. 101 indexed citations
16.
Oka, Daizo, Kazuo Nishimura, Masahiro Shiba, et al.. (2005). Growth inhibition by Parthenolide in renal cell carcinoma. Cancer Research. 65. 193–193. 1 indexed citations
17.
Nakai, Yasutomo, Norio Nonomura, Daizo Oka, et al.. (2005). KIT (c-kit oncogene product) pathway is constitutively activated in human testicular germ cell tumors. Biochemical and Biophysical Research Communications. 337(1). 289–296. 41 indexed citations
18.
Inoue, Hitoshi, Kazuo Nishimura, Daizo Oka, et al.. (2004). Prostate cancer mediates osteoclastogenesis through two different pathways. Cancer Letters. 223(1). 121–128. 28 indexed citations
19.
Ujike, Takeshi, et al.. (2003). [Squamous cell carcinoma of the renal pelvis with giant hydronephrosis].. PubMed. 49(12). 757–9. 4 indexed citations
20.
Ujike, Takeshi, et al.. (2003). [Urethral stent (Memotherm) for the treatment of benign prostatic hyperplasia].. PubMed. 49(11). 645–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026